Literature DB >> 27578866

Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.

Takeshi Ueda1, Yuichiro Nakata2, Akiko Nagamachi3, Norimasa Yamasaki2, Akinori Kanai3, Yasuyuki Sera2, Masato Sasaki4, Hirotaka Matsui3, Zen-Ichiro Honda5, Hideaki Oda6, Linda Wolff7, Toshiya Inaba3, Hiroaki Honda1.   

Abstract

Polycomb repressive complex 2 (PRC2) catalyzes the monomethylation, dimethylation, and trimethylation of histone H3 Lys27 (H3K27) and acts as a central epigenetic regulator that marks the repressive chromatin domain. Embryonic ectoderm development (EED), an essential component of PRC2, interacts with trimethylated H3K27 (H3K27me3) through the aromatic cage structure composed of its three aromatic amino acids, Phe97, Trp364, and Tyr365. This interaction allosterically activates the histone methyltransferase activity of PRC2 and thereby propagates repressive histone marks. In this study, we report the analysis of knock-in mice harboring the myeloid disorder-associated EED Ile363Met (I363M) mutation, analogous to the EED aromatic cage mutants. The I363M homozygotes displayed a remarkable and preferential reduction of H3K27me3 and died at midgestation. The heterozygotes increased the clonogenic capacity and bone marrow repopulating activity of hematopoietic stem/progenitor cells (HSPCs) and were susceptible to leukemia. Lgals3, a PRC2 target gene encoding a multifunctional galactose-binding lectin, was derepressed in I363M heterozygotes, which enhanced the stemness of HSPCs. Thus, our work provides in vivo evidence that the structural integrity of EED to H3K27me3 propagation is critical, especially for embryonic development and hematopoietic homeostasis, and that its perturbation increases the predisposition to hematologic malignancies.

Entities:  

Keywords:  hematologic malignancies; histone methylation; repressive histone marks

Mesh:

Substances:

Year:  2016        PMID: 27578866      PMCID: PMC5027452          DOI: 10.1073/pnas.1600070113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.

Authors:  R G Sewalt; J van der Vlag; M J Gunster; K M Hamer; J L den Blaauwen; D P Satijn; T Hendrix; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia.

Authors:  Mio Yamamoto-Sugitani; Junya Kuroda; Eishi Ashihara; Hisao Nagoshi; Tsutomu Kobayashi; Yosuke Matsumoto; Nana Sasaki; Yuji Shimura; Miki Kiyota; Ryuko Nakayama; Kenichi Akaji; Tomohiko Taki; Nobuhiko Uoshima; Yutaka Kobayashi; Shigeo Horiike; Taira Maekawa; Masafumi Taniwaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma.

Authors:  Stanley C W Lee; Belinda Phipson; Craig D Hyland; Huei San Leong; Rhys S Allan; Aaron Lun; Douglas J Hilton; Stephen L Nutt; Marnie E Blewitt; Gordon K Smyth; Warren S Alexander; Ian J Majewski
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

5.  Point mutations in the WD40 domain of Eed block its interaction with Ezh2.

Authors:  O Denisenko; M Shnyreva; H Suzuki; K Bomsztyk
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

6.  Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia.

Authors:  Martin Sauvageau; Michelle Miller; Sébastien Lemieux; Julie Lessard; Josée Hébert; Guy Sauvageau
Journal:  Blood       Date:  2007-09-28       Impact factor: 22.113

7.  Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal.

Authors:  Deqiang Sun; Min Luo; Mira Jeong; Benjamin Rodriguez; Zheng Xia; Rebecca Hannah; Hui Wang; Thuc Le; Kym F Faull; Rui Chen; Hongcang Gu; Christoph Bock; Alexander Meissner; Berthold Göttgens; Gretchen J Darlington; Wei Li; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2014-05-01       Impact factor: 24.633

8.  Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.

Authors:  Serena Sanulli; Neil Justin; Aurélie Teissandier; Katia Ancelin; Manuela Portoso; Matthieu Caron; Audrey Michaud; Berangère Lombard; Simao T da Rocha; John Offer; Damarys Loew; Nicolas Servant; Michel Wassef; Fabienne Burlina; Steve J Gamblin; Edith Heard; Raphaël Margueron
Journal:  Mol Cell       Date:  2015-01-22       Impact factor: 17.970

9.  Role of the polycomb protein EED in the propagation of repressive histone marks.

Authors:  Raphael Margueron; Neil Justin; Katsuhito Ohno; Miriam L Sharpe; Jinsook Son; William J Drury; Philipp Voigt; Stephen R Martin; William R Taylor; Valeria De Marco; Vincenzo Pirrotta; Danny Reinberg; Steven J Gamblin
Journal:  Nature       Date:  2009-09-20       Impact factor: 49.962

10.  Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity.

Authors:  Ian J Majewski; Marnie E Blewitt; Carolyn A de Graaf; Edward J McManus; Melanie Bahlo; Adrienne A Hilton; Craig D Hyland; Gordon K Smyth; Jason E Corbin; Donald Metcalf; Warren S Alexander; Douglas J Hilton
Journal:  PLoS Biol       Date:  2008-04-15       Impact factor: 8.029

View more
  15 in total

Review 1.  Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.

Authors:  Yiran Guo; Shuai Zhao; Gang Greg Wang
Journal:  Trends Genet       Date:  2021-01-22       Impact factor: 11.639

2.  Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.

Authors:  Yuichiro Nakata; Takeshi Ueda; Akiko Nagamachi; Norimasa Yamasaki; Ken-Ichiro Ikeda; Yasuyuki Sera; Keiyo Takubo; Akinori Kanai; Hideaki Oda; Masashi Sanada; Seishi Ogawa; Kohichiro Tsuji; Yasuhiro Ebihara; Linda Wolff; Zen-Ichiro Honda; Toshio Suda; Toshiya Inaba; Hiroaki Honda
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

3.  Loss of microglial EED impairs synapse density, learning, and memory.

Authors:  Ying-Ying Wang; Yu-Sen Deng; Shang-Kun Dai; Ting-Wei Mi; Rui-Yang Li; Pei-Pei Liu; Cong Liu; Bao-Dong He; Xuan-Cheng He; Hong-Zhen Du; Han-Chen Yang; Yi Tang; Chang-Mei Liu; Zhao-Qian Teng
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

Review 4.  The language of chromatin modification in human cancers.

Authors:  Shuai Zhao; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2021-05-17       Impact factor: 60.716

5.  Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics.

Authors:  Yuping Ren; Eunjin Choi; Ke Zhang; Yu Chen; Sha Ye; Xiaoling Deng; Kangling Zhang; Xiaoyong Bao
Journal:  Vaccines (Basel)       Date:  2017-12-03

6.  Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.

Authors:  Yunan Li; Mingying Zhang; Mengyao Sheng; Peng Zhang; Zizhen Chen; Wen Xing; Jie Bai; Tao Cheng; Feng-Chun Yang; Yuan Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-28       Impact factor: 4.553

7.  Discovery of selective activators of PRC2 mutant EED-I363M.

Authors:  Junghyun L Suh; Kimberly D Barnash; Tigran M Abramyan; Fengling Li; Juliana The; Isabelle A Engelberg; Masoud Vedadi; Peter J Brown; Dmitri B Kireev; Cheryl H Arrowsmith; Lindsey I James; Stephen V Frye
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

Review 8.  PRC2 is high maintenance.

Authors:  Jia-Ray Yu; Chul-Hwan Lee; Ozgur Oksuz; James M Stafford; Danny Reinberg
Journal:  Genes Dev       Date:  2019-05-23       Impact factor: 11.361

9.  Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.

Authors:  Reina Nagase; Daichi Inoue; Alessandro Pastore; Takeshi Fujino; Hsin-An Hou; Norimasa Yamasaki; Susumu Goyama; Makoto Saika; Akinori Kanai; Yasuyuki Sera; Sayuri Horikawa; Yasunori Ota; Shuhei Asada; Yasutaka Hayashi; Kimihito Cojin Kawabata; Reina Takeda; Hwei-Fang Tien; Hiroaki Honda; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Exp Med       Date:  2018-04-11       Impact factor: 14.307

Review 10.  Polycomb complexes in normal and malignant hematopoiesis.

Authors:  Valerio Di Carlo; Ivano Mocavini; Luciano Di Croce
Journal:  J Cell Biol       Date:  2018-10-19       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.